Publication | Closed Access

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

OncologyClinical TrialsChemotherapy-naive PatientsImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentPemetrexed Versus ChemotherapyMedicineRadiation OncologyLung CancerPhase 3Health Sciences